generic glp 1 Liraglutide (Victoza) Becomes First Generic GLP-1 Receptor Agonist First Generic of Once-Daily GLP-1
Description
Risk of bias: all four RCTs were rated low risk by RoB2 (with some concerns for open-label outcome ascertainment in three trials, a domain-specific issue that does not alter the overall RoB2 category from low)
Learn why GLP-1 drugs cannot rebuild metabolism, and how SCFAs & gut bacteria may support lasting balance
The primary endpoint was the percentage weight loss at six months (M6) compared to baseline
Liquivida offers medically supervised GLP-1 weight loss injections
Not for use during pregnancy or nursing without guidance from your provider
